UNSPSC 51112600: Alkylating agent nitrosourea compounds

This classification denotes compounds that bear a nitroso (R-NO) group and a urea, substances called nitrosoureas, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term ALKYLATING AGENT NITROSOUREA COMPOUNDS.

UNSPSC 51112600 Alkylating agent nitrosourea compounds is a Class code covering pharmaceutical products used in oncology and related therapeutic applications that state and local health agencies procure through pharmacy benefit and direct-contracting channels. State and local governments acquire these specialized chemotherapy compounds primarily through health and human services departments managing employee health plans, Medicaid programs, and institutional healthcare systems. The procuring bodies include state health departments, state employee benefit programs, and county or municipal health authorities that operate or oversee pharmacy benefit management and drug procurement infrastructure.

Recent activity centers on Texas, where the Texas Health and Human Services Commission posted Request for Information HHS0017013 on April 3, 2026, to gather vendor capabilities and market intelligence on direct-to-manufacturer prescription programs that would bypass traditional pharmacy benefit managers and group purchasing organizations. The RFI seeks vendor experience with direct contracting for self-insured employer and government health plans, capacity to negotiate net pricing models without rebates, and ability to implement value-based or outcomes-based service agreements. The state is using this information-gathering phase to inform future procurement strategy before issuing a formal Request for Proposal with established financial and temporal parameters. No award value or response deadline extension appears in the current materials; the RFI functions as exploratory procurement to assess available solutions and vendor capabilities rather than a binding competitive solicitation.